Dublin, March 10, 2022 (GLOBE NEWSWIRE) -- The "Interventional Pulmonology Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029" report has been added to ResearchAndMarkets.com's offering.
The interventional pulmonology market is set to grow at a compounded annual growth rate (CAGR) of 4.8% during the forecast period from 2021 to 2029.
As per the statistics provided by World Health Organization (WHO), in 2018 approximately 2.09 million people died due to lung cancer. Tobacco smoking is the leading causes of formation of malignant tumours and neoplasms in the lungs.
Interventional pulmonology is a relatively new field which has gained tremendous attraction in the last decade which employs sophisticated tools to perform diagnosis and treatment of various pulmonary disorders. Apart from pulmonologist cardiothoracic surgeons also routinely perform interventional pulmonology procedures.
Accurate diagnosis, precise sample collection and increasing number of lung complications drive the flexible bronchoscopy market growth
Flexible bronchoscopy is dominating the procedure type segment for interventional pulmonology market. Flexible bronchoscopy is useful in diagnosing different stages of lung cancer, palliative care by debulking endobronchial lesions and treating in airway stenosis. Its inherent features such as accurate diagnosis, precise sample collection and significant rise in lung complication together drive the flexible bronchoscopy market growth.
Pleuroscopy is gaining huge demand as an alternative to video assisted thoracoscopic surgery (VATS) which is employed for the diagnosis of pleural effusion of unknown etiology. It is a minimally invasive surgical procedure and has successfully achieved 100% accurate diagnosis of tuberculous effusion. It is relatively well tolerated procedure with negligible complications.
Rising prevalence of lung cancer and growing health awareness together drive the market growth in North America
In the current scenario North America is dominating the regional segment for interventional pulmonology market. The factors responsible for its market share of 35% are rising prevalence of lung cancer and growing health awareness.
According to American Lung Association (ALA) in 2018, 234,030 new cases of lung cancer were diagnosed in the United States which represents 13% of all diagnosed cancer. Europe holds 30% market share owing to the significant rise in air pollution and tobacco smoking. Stringent norms related to early diagnosis and medical intervention drive the interventional pulmonology market growth in European region.
Asia Pacific is representing 15% market share on account of increasing establishment of subsidiaries and retail outlets of major players such as Boston Scientific Corporation, Karl Storz, Medtronic, Plc., and Terumo Corporation etc. Supportive regulatory environment provided by regional healthcare bodies further bolster the market growth in Asia Pacific region.
Medical device companies competing in interventional pulmonology market are
- Boston Scientific Corporation
- BTG Plc.
- Ethicon Inc.
- ENDO-FLEX GmbH
- HealthTronics Inc.
- Karl Storz
- Medtronic Plc.
- Pulmonx Inc.
- Terumo Corporation
- Varian Medical Systems Inc.
Key Topics Covered:
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Scope
1.3. Research Methodology
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global IP Market Portraiture
2.2. Global IP Market, by Procedure, 2020(US$ Mn)
2.3. Global IP Market, by Geography, 2020(US$ Mn)
Chapter 3. Interventional Pulmonology (IP)Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2020
3.6. Competitive Analysis: Global IP Market, by Key Players, 2020
Chapter 4. Global Interventional Pulmonology (IP) Market, by Procedure
4.1. Overview
4.2. Flexible Bronchoscopy
4.3. Rigid Bronchoscopy
4.4. Bronchoalveolar Lavage
4.5. Lung Biopsy
4.6. Bronchial Stent
4.7. Balloon Bronchoplasty
4.8. Pleuroscopy
4.9. Others
Chapter 5. Global Interventional Pulmonology (IP) Market, by Geography
5.1. Overview
5.2. North America IP Market Analysis, 2019 - 2029
5.2.1. North America IP Market, by Procedure, 2019 - 2029(US$ Mn)
5.2.2. North America IP Market, by Country, 2019 - 2029(US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe IP Market Analysis, 2019 - 2029
5.3.1. Europe IP Market, by Procedure, 2019 - 2029(US$ Mn)
5.3.2. Europe IP Market, by Country/Region, 2019 - 2029(US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific IP Market Analysis, 2019 - 2029
5.4.1. Asia Pacific IP Market, by Procedure, 2019 - 2029(US$ Mn)
5.4.2. Asia Pacific IP Market, by Country/Region, 2019 - 2029(US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America IP Market Analysis, 2019 - 2029
5.5.1. Latin America IP Market, by Procedure, 2019 - 2029(US$ Mn)
5.5.2. Latin America IP Market, by Country/Region, 2019 - 2029(US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa IP Market Analysis, 2019 - 2029
5.6.1. MEA IP Market, by Procedure, 2019 - 2029(US$ Mn)
5.6.2. MEA IP Market, by Region, 2019 - 2029(US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA
Chapter 6. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/o6jd7x
